Report: Addressing the Unmet Treatment Demand for Buprenorphine, a Lifesaving Medication for Opioid Use Disorder

Written By Erin Schanning

Today, End Substance Use Disorder issued a report on how to build universal access to a life-saving overdose prevention medicine, buprenorphine.

This report summarizes the research on when healthcare providers opt out of prescribing buprenorphine and why they choose not to prescribe the medication to people with opioid use disorder.

The report then provides policy solutions to ensure that every American with opioid use disorder can access buprenorphine.

To read the report, click here.

Erin Schanning
Previous

Ahead of Congressional Hearing, End Substance Use Disorder Issues Letter of Support for the Bipartisan Mainstreaming Addiction Treatment Act
Next

End Substance Use Disorder Commends Mayor Marty Walsh on His Confirmation to the Cabinet